Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma DISCUSSION

被引:91
作者
Shaha, Ashok R.
Arora, Nimmi
Evans, Douglas B.
Doherty, Gerard M.
Dralle, Henning
机构
[1] Department of Surgery, New York Presbyterian Hospital-Cornell University, New York, NY
[2] Department of Pathology, New York Presbyterian Hospital-Cornell University, New York, NY
[3] Department of Radiology, New York Presbyterian Hospital-Cornell University, New York, NY
关键词
D O I
10.1016/j.surg.2008.07.023
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Extrathyroidal extension (ETE) is a risk factor for recurrence of papillary thyroid carcinoma (PTC). Although initial data supporting this was based on gross ETE noted at surgery, current treatment regimens group patients with microscopic ETE-identified only on histopathology-similarly to those with macroscopic (gross) ETE. This study was designed to assess the influence of microscopic ETE on disease recurrence. Methods: Retrospective analysis of 212 patients undergoing thyroidectomy for PTC between 1995 and 2004 with minimum 3-year follow-up was conducted. Results: Of 212 patients, 71 had ETE; 32% were macroscopic and 68% microscopic. Patient demographics, tumor variables, and adjuvant therapy were similar between both ETE groups. Recurrence rates were 52% for macroscopic ETE, 21% for microscopic ETE, and 13% without ETE. On multivariate analysis, patients with macroscopic ETE had a 6.4-fold increased relative risk of recurrence compared with patients with microscopic ETE (P < .02; 95% confidence interval, 1.6-25.9) and a significantly decreased disease-free survival (DFS). Furthermore, patients with microscopic ETE had neither a significantly increased risk of recurrence nor different DFS compared with patients without ETE. Conclusion: Macroscopic ETE has a higher incidence of disease recurrence than microscopic ETE, implying they should be considered separately when devising adjuvant treatment regimens. The significance of microscopic ETE is undetermined. © 2008 Mosby, Inc. All rights reserved.
引用
收藏
页码:947 / 948
页数:2
相关论文
共 19 条
[1]   DIFFERENTIATED CARCINOMA OF THE THYROID WITH EXTRATHYROIDAL EXTENSION [J].
ANDERSEN, PE ;
KINSELLA, J ;
LOREE, TR ;
SHAHA, AR ;
SHAH, JP .
AMERICAN JOURNAL OF SURGERY, 1995, 170 (05) :467-470
[2]  
CADY B, 1988, SURGERY, V104, P947
[3]  
CARCANGIU ML, 1985, CANCER, V55, P805, DOI 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO
[4]  
2-Z
[5]   Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer [J].
Cross, S. ;
Wei, J. P. ;
Kim, S. ;
Brams, D. M. .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (08) :678-682
[6]  
Gemsenjäger E, 2001, SWISS MED WKLY, V131, P157
[7]  
Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO
[8]  
2-0
[9]   Papillary thyroid carcinoma in Mexican patients: Clinical aspects and prognostic factors [J].
Herrera, MF ;
LopezGraniel, CM ;
Saldana, J ;
GamboaDominguez, A ;
RichaudPatin, Y ;
VargasVorackova, F ;
AngelesAngeles, A ;
Llorente, L ;
Castillo, C ;
Perez, B ;
Rivera, R ;
Gonzalez, O ;
Rull, J .
WORLD JOURNAL OF SURGERY, 1996, 20 (01) :94-100
[10]   Extrathyroidal extension in well-differentiated thyroid cancer - Macroscopic vs microscopic as a predictor of outcome [J].
Hu, Amanda ;
Clark, Jonathan ;
Payne, Richard J. ;
Eski, Spiro ;
Walfish, Paul G. ;
Freeman, Jeremy L. .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2007, 133 (07) :644-649